GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Teva Pharmaceutical Industries Ltd. ADR-0.81% $21.06B ...

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

As of October 31, 2024, GSK plc (ADR) had a $73.6 billion market capitalization, putting it in the 96th percentile of companies in the Pharmaceuticals industry. Currently, GSK plc (ADR)’s ...

Copyright © 2024 MarketWatch, Inc. All rights reserved.

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 44,547.01 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

GlaxoSmithKline ( (GSK)) has realeased its Q3 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors. GlaxoSmithKline (GSK) is a global biopharmaceutical ...

Aditya Birla SL ELSS Tax Saver Fund (IDCW) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund (G) 262.21 9,53,316 1.53 Aditya Birla SL ELSS Tax Saver Fund ...